Zeer European Medicines Agency / intent / european-medicines-agency

European Medicines Agency

501-1000 employees·Amsterdam, North Holland, Netherlands·ema.europa.eu

Observed, not inferred · updated weekly

Buying intent

19 tracked signals | Top 15 topics are below.

15signals · 30 days
19topics tracked
0%attributed to a team

Attention by team

LinkedIn activity, by team

Where European Medicines Agency's own people are actually spending their attention, by team, by topic. Bands run Low to High against the busiest pairing on this page, and each cell also shows how much of that team's own activity it represents.

Software system test and evaluation process
High-impact system
Global pricing management
Use Case
Infrastructure Modernization
Health Care
Others
High17% of team Others to Software system test and evaluation process: High, 17% of this team's signals
High17% of team Others to High-impact system: High, 17% of this team's signals
High17% of team Others to Global pricing management: High, 17% of this team's signals
High17% of team Others to Use Case: High, 17% of this team's signals
High17% of team Others to Infrastructure Modernization: High, 17% of this team's signals
High17% of team Others to Health Care: High, 17% of this team's signals
LowMediumHigh·  banded against the busiest pairing on this page

Topics being researched

30-day window

Every tracked topic, ranked by volume, not by our guess at what matters. Confidence is the classifier's own certainty that a signal belongs where we've filed it.

Software system test and evaluation process
LinkedIn
High volume
94%
last
29d ago
High-impact system
LinkedIn
High volume
98%
last
29d ago
Global pricing management
LinkedIn
High volume
98%
last
16d ago
Use Case
LinkedIn
High volume
98%
last
9d ago
Infrastructure Modernization
LinkedIn
High volume
98%
last
15d ago
Health Care
LinkedIn
High volume
98%
last
16d ago
Pharmaceutical Manufacturing
LinkedIn
High volume
98%
last
4d ago
Cancer Research
LinkedIn
High volume
98%
last
29d ago
Artificial Intelligence
LinkedIn
High volume
96%
last
9d ago
Resource Allocation
LinkedIn
High volume
98%
last
4d ago
Pharmaceuticals
LinkedIn
High volume
98%
last
29d ago
Cross-Border Solutions
LinkedIn
High volume
98%
last
15d ago
Opt-Out
LinkedIn
High volume
98%
last
29d ago
Pharmaceutical
LinkedIn
High volume
94%
last
22d ago
Healthcare Interoperability
LinkedIn
High volume
98%
last
16d ago

Need intent for a specific topic or industry?

We track the full taxonomy across every account in the graph — including themes not shown on this page.

Talk to us

Who's active at European Medicines Agency

verified title on file

Titles, seniority and topic straight from each person's own activity, with a LinkedIn link so you can check any of them yourself.

Others5 active
researching Image Recognition
in
researching Software system test and evaluation process
in
researching High-impact system
in
researching Health Care
in

Primary products / business lines

LinkedIn company profile

The European Medicines Agency (EMA) is a decentralised body of the European Union with headquarters in Amsterdam. Its main responsibility is the protection and promotion of public and animal health, through the evaluation and supervision of medicines for human and veterinary use.

Top accounts researching European Medicines Agency

names withheld on the public page

These are companies whose own people brought up European Medicines Agency unprompted, not accounts we guessed might be interested. We can't yet tell an implementation partner from a genuine buyer here, names unlock along with the buyer profile below.

343 companies · 974 people are researching Software system test and evaluation process

European Medicines Agency's own team shows 1 signal on this topic. No one outside European Medicines Agency has been seen researching the company by name yet — so this is the market it sits in, not a list of its buyers.

  • High-impact system5,974 cos · 17,680 people
  • Global pricing management42 cos · 108 people
Sign up to see which companies →

Buyer profile

company size · seniority

Company size and how senior the people involved are, the two things that decide whether this is a real deal. Competitor overlap isn't computed yet for this account.

Unlock the buyer profile

Company-size breakdown and buyer seniority mix for accounts researching European Medicines Agency.

Company size breakdown
Buyer seniority mix

Sign up to learn more

Create an account to explore buyer insights as they become available.

Sign up to learn more →

What's been said

public posts mentioning European Medicines Agency

Up to 9 public excerpts naming European Medicines Agency from the past 365 days, across LinkedIn, Reddit, X, YouTube and other public sources.

LinkedIn

This #WorldVeterinaryDay , I want to recognise the vital contribution veterinarians make every day to animal health and welfare, to food safety, and to public health across Europe and beyond. Veterinarians are often the first line of defence against animal disease. Whether on farms, in clinics, in laboratories, or elsewhere in the field. Through their work, they safeguard not only the wellbeing of animals, but also the confidence consumers place in the food on their plates. This connection between animal and human health is at the heart of the One Health approach. At the European Medicines Agency , veterinary medicine is a core part of our public health mission. Alongside our partners across the EU, we work to ensure veterinary medicines are effective, safe and responsibly used. Supporting veterinarians in their work and helping to protect society as a whole. One important – though sometimes less visible – part of this work is EMA’s role in recommending maximum residue limits (MRLs) for veterinary medicines used in food-producing animals. When veterinary medicines are used in animals raised for food, its essential to ensure that any residue remaining in meat, milk and eggs are at levels that are safe for consumers. MRLs define the highest level of residue legally permitted in food. In order to establish MRLs, EMA’s Committee for Veterinary Medicinal Products, together with scientific experts from across the EU, evaluates data on how medicines are absorbed, distributed and eliminated from animals. Veterinarians play a vital role in this process by prescribing or administering authorised medicines in accordance with product information, respecting the dose and the withdrawal period. This ensures that residues in food remain below the established MRL, and thus food of animal origin on the market remains safe, compliant, and fit for consumption. This process is a clear example of how science, regulation and veterinary practice come together in the public interest. It supports food safety, underpins trust in the EU regulatory system, and helps ensure that veterinary medicines can continue to be used responsibly where they are needed. Today, veterinary professionals face complex and evolving challenges, from emerging animal diseases and antimicrobial resistance to sustainability and climate pressures. Regulation must evolve alongside these realities. At EMA, our work is ultimately about enabling veterinarians to do what they do best: make informed clinical decisions, protect animal health and welfare, and act as partners in safeguarding public health. To all veterinarians across Europe and around the world, thank you for your commitment, expertise and dedication.

Apr 2026

About this data. European Medicines Agency (ema.europa.eu). Department attribution is 0%; remaining activity is grouped under Others. Updated 2026-09-25T18:00:10.181Z.

Not yet computedPer-team narrative summaries